Follow-The-Filings

Security · featured owners

PYXS Pyxis Oncology Inc.

COMMON STOCK Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.4%
  • $3M
  • 1 reduce

Who owns this now

Largest portfolio weights among featured holders · max 0.4% (Palo Alto Investors) · not free-float ownership

  1. Palo Alto Investors reduce 0.36%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Palo Alto Investors 2026 Q2 0.36% Reduce −14.5% 864,277 $3M history

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 22 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02 Filing Doc
10-Q Filing Doc
8-K 1.01,3.02,7.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02 Filing Doc
10-Q Filing Doc
8-K/A 5.02 Filing Doc
DEFA14A Filing Doc
8-K 2.02,7.01 Filing Doc
10-K Filing Doc
8-K 9.01 Filing Doc
8-K 7.01,8.01 Filing Doc
8-K 2.02 Filing Doc
10-Q Filing Doc
8-K 2.02 Filing Doc
10-Q Filing Doc
8-K 8.01 Filing Doc
8-K 5.02 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,7.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 7 rows shown

Filed Form Detail Links
4 Period Aug 20, 2026 Filing Doc
4 Period Aug 12, 2026 Filing Doc
4 Period Jun 30, 2026 Filing Doc
4 Period Apr 14, 2025 Filing Doc
4 Period Mar 24, 2026 · 8 forms Filing Doc
4 Period Feb 3, 2026 Filing Doc
4 Period Mar 31, 2025 · 5 forms Filing Doc

Updated 8 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — $16.15M $13.86M
Gross profit * — $15.67M $11.47M
Gross margin * — 97.1% 82.8%
Net income -$73.79M -$77.33M -$79.62M
Net margin * — -478.9% -574.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $124.6M $132.44M $72.1M
Total non-current assets * $49.12M $24.74M $19.42M
Total assets $173.73M $157.18M $91.52M
Total current liabilities $25.76M $17.68M $21.13M
Total non-current liabilities * $22.26M $18.75M $16.98M
Total equity $125.7M $120.75M $53.41M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$70.71M -$57.67M -$63.5M
Cash from investing -$104.85M $8.16M $58.86M
Cash from financing $5.93M $59.33M $0.594M
Net change in cash -$169.63M $9.81M -$4.05M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders